世界中の市場調査レポートを販売!当社に無いレポートもお探しします。

レポートナンバー 0000039456

肉腫治療薬の世界市場(2024-2028)

TechNavio

Global sarcoma therapeutics market 2024-2028

発刊日 2024/06/13

言語英語

体裁PDF/143ページ

ライセンス/価格143ページ

0000039456

Single
Enterprise

※ご請求は、お申込日のTTSレートで円換算し、消費税を加えた金額になります。
※本レポートは、英文です。PDF(電子媒体)での納品となります。
※本レポートは取り寄せとなりますので、申し込みからお届けまで、多少時間が掛かる場合がございます。

無料サンプル

  • サンプルはお問い合わせください。

レポート概要

肉腫治療薬市場は2023年から2028年に11億1,080万米ドル、予測期間中のCAGRは8.51%で成長すると予測されます。このレポートは、全体的な分析、市場規模と予測、傾向、成長ドライバー、課題、および約25のベンダーをカバーするベンダー分析を提供します。

このレポートは、現在の市場シナリオ、最新の傾向と推進力、および全体的な市場環境に関する最新の分析を提供します。患者支援プログラム、戦略的提携の増加、新薬の発売などが市場を牽引しています。

調査範囲

  • 市場セグメント
    ➣ タイプ別
      ◇ 軟部肉腫
      ◇ 骨肉腫

この調査では、今後数年間の肉腫治療薬市場成長を牽引する主要因の1つとして、疾病治療のための新薬の研究開発を挙げています。また、財政支援プログラムや償還スキーム、再生医療の出現は市場の大きな需要につながります。

肉腫治療薬市場に関するレポートは、次の分野をカバーしています。

  • 肉腫治療薬市場の規模
  • 肉腫治療薬市場の予測
  • 肉腫治療薬市場の業界分析

堅牢なベンダー分析は、クライアントが市場での地位を向上させるのに役立つように設計されています。

  • 調査企業
    ➣ Adaptimmune Therapeutics plc
    ➣ Advenchen Laboratories LLC
    ➣ Agenus Inc.
    ➣ Agios Inc.
    ➣ Athenex Inc.
    ➣ Bayer AG
    ➣ Bristol Myers Squibb Co.
    ➣ エーザイ(Eisai Co. Ltd.)
    ➣ Eli Lilly and Co.
    ➣ GlaxoSmithKline Plc
    ➣ Ipsen Pharma
    ➣ Johnson and Johnson Services Inc.
    ➣ Karyopharm Therapeutics Inc.
    ➣ LadRx Corp.
    ➣ Mirati Therapeutics Inc.
    ➣ Novartis AG, Pfizer Inc.
    ➣ PharmaMar SA
    ➣ SillaJen Co. Ltd.

また、本レポートには、市場の成長に影響を与える今後の傾向と課題に関する情報が含まれています。これは、企業が今後のすべての成長機会を戦略化し、活用するのに役立ちます。

この調査は、業界の主要参加者からの意見を含む一次情報と二次情報を客観的に組み合わせて実施されました。このレポートには、主要ベンダーの分析に加えて、包括的な市場とベンダーの状況が含まれています。

このレポートは、利益、価格設定、競争、プロモーションなどの主要なパラメーターの分析による複数のソースからのデータの調査、合成、合計により、市場の詳細な全体像を提示します。業界の主要な影響力を持つ企業を特定することで、さまざまな市場の側面を示します。提示されたデータは包括的で信頼性が高く、一次および二次の両方にわたる広範な研究の結果です。市場調査レポートは、正確な市場の成長を予測するための定性的および定量的調査を使用した、完全な競争状況と詳細なベンダー選択方法論および分析を提供します。

レポート詳細

目次

Table of Contents

1 Executive Summary
1.1 Market overview
Executive Summary - Chart on Market Overview
Executive Summary - Data Table on Market Overview
Executive Summary - Chart on Global Market Characteristics
Executive Summary - Chart on Market by Geography
Executive Summary - Chart on Market Segmentation by Type
Executive Summary - Chart on Incremental Growth
Executive Summary - Data Table on Incremental Growth
Executive Summary - Chart on Company Market Positioning

2 Market Landscape
2.1 Market ecosystem
Parent Market
Data Table on - Parent Market
2.2 Market characteristics
Market characteristics analysis
2.3 Value chain analysis
Value Chain Analysis

3 Market Sizing
3.1 Market definition
Offerings of companies included in the market definition
3.2 Market segment analysis
Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Chart on Global - Market size and forecast 2023-2028 ($ million)
Data Table on Global - Market size and forecast 2023-2028 ($ million)
Chart on Global Market: Year-over-year growth 2023-2028 (%)
Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size
4.1 Global Sarcoma Therapeutics Market 2018 - 2022
Historic Market Size - Data Table on Global Sarcoma Therapeutics Market 2018 - 2022 ($ million)
4.2 Type segment analysis 2018 - 2022
Historic Market Size - Type Segment 2018 - 2022 ($ million)
4.3 Geography segment analysis 2018 - 2022
Historic Market Size - Geography Segment 2018 - 2022 ($ million)
4.4 Country segment analysis 2018 - 2022
Historic Market Size - Country Segment 2018 - 2022 ($ million)

5 Five Forces Analysis
5.1 Five forces summary
Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by Type
6.1 Market segments
Chart on Type - Market share 2023-2028 (%)
Data Table on Type - Market share 2023-2028 (%)
6.2 Comparison by Type
Chart on Comparison by Type
Data Table on Comparison by Type
6.3 Soft tissue sarcoma - Market size and forecast 2023-2028
Chart on Soft tissue sarcoma - Market size and forecast 2023-2028 ($ million)
Data Table on Soft tissue sarcoma - Market size and forecast 2023-2028 ($ million)
Chart on Soft tissue sarcoma - Year-over-year growth 2023-2028 (%)
Data Table on Soft tissue sarcoma - Year-over-year growth 2023-2028 (%)
6.4 Osteosarcoma - Market size and forecast 2023-2028
Chart on Osteosarcoma - Market size and forecast 2023-2028 ($ million)
Data Table on Osteosarcoma - Market size and forecast 2023-2028 ($ million)
Chart on Osteosarcoma - Year-over-year growth 2023-2028 (%)
Data Table on Osteosarcoma - Year-over-year growth 2023-2028 (%)
6.5 Market opportunity by Type
Market opportunity by Type ($ million)
Data Table on Market opportunity by Type ($ million)

7 Customer Landscape
7.1 Customer landscape overview
Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

8 Geographic Landscape
8.1 Geographic segmentation
Chart on Market share by geography 2023-2028 (%)
Data Table on Market share by geography 2023-2028 (%)
8.2 Geographic comparison
Chart on Geographic comparison
Data Table on Geographic comparison
8.3 North America - Market size and forecast 2023-2028
Chart on North America - Market size and forecast 2023-2028 ($ million)
Data Table on North America - Market size and forecast 2023-2028 ($ million)
Chart on North America - Year-over-year growth 2023-2028 (%)
Data Table on North America - Year-over-year growth 2023-2028 (%)
8.4 Europe - Market size and forecast 2023-2028
Chart on Europe - Market size and forecast 2023-2028 ($ million)
Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Chart on Europe - Year-over-year growth 2023-2028 (%)
Data Table on Europe - Year-over-year growth 2023-2028 (%)
8.5 Asia - Market size and forecast 2023-2028
Chart on Asia - Market size and forecast 2023-2028 ($ million)
Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Chart on Asia - Year-over-year growth 2023-2028 (%)
Data Table on Asia - Year-over-year growth 2023-2028 (%)
8.6 Rest of World (ROW) - Market size and forecast 2023-2028
Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
8.7 US - Market size and forecast 2023-2028
Chart on US - Market size and forecast 2023-2028 ($ million)
Data Table on US - Market size and forecast 2023-2028 ($ million)
Chart on US - Year-over-year growth 2023-2028 (%)
Data Table on US - Year-over-year growth 2023-2028 (%)
8.8 China - Market size and forecast 2023-2028
Chart on China - Market size and forecast 2023-2028 ($ million)
Data Table on China - Market size and forecast 2023-2028 ($ million)
Chart on China - Year-over-year growth 2023-2028 (%)
Data Table on China - Year-over-year growth 2023-2028 (%)
8.9 Germany - Market size and forecast 2023-2028
Chart on Germany - Market size and forecast 2023-2028 ($ million)
Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Chart on Germany - Year-over-year growth 2023-2028 (%)
Data Table on Germany - Year-over-year growth 2023-2028 (%)
8.10 Canada - Market size and forecast 2023-2028
Chart on Canada - Market size and forecast 2023-2028 ($ million)
Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Chart on Canada - Year-over-year growth 2023-2028 (%)
Data Table on Canada - Year-over-year growth 2023-2028 (%)
8.11 UK - Market size and forecast 2023-2028
Chart on UK - Market size and forecast 2023-2028 ($ million)
Data Table on UK - Market size and forecast 2023-2028 ($ million)
Chart on UK - Year-over-year growth 2023-2028 (%)
Data Table on UK - Year-over-year growth 2023-2028 (%)
8.12 Market opportunity by geography
Market opportunity by geography ($ million)
Data Tables on Market opportunity by geography ($ million)

9 Drivers, Challenges, and Opportunity/Restraints
9.1 Market drivers
9.2 Market challenges
9.3 Impact of drivers and challenges
Impact of drivers and challenges in 2023 and 2028
9.4 Market opportunities/restraints

10 Competitive Landscape
10.1 Overview
10.2 Competitive Landscape
Overview on criticality of inputs and factors of differentiation
10.3 Landscape disruption
Overview on factors of disruption
10.4 Industry risks
Impact of key risks on business

11 Competitive Analysis
11.1 Companies profiled
Companies covered
11.2 Market positioning of companies
Matrix on companies position and classification
11.3 Agios Inc.
Agios Inc. - Overview
Agios Inc. - Product / Service
Agios Inc. - Key offerings
11.4 Athenex Inc.
Athenex Inc. - Overview
Athenex Inc. - Product / Service
Athenex Inc. - Key offerings
11.5 Bayer AG
Bayer AG - Overview
Bayer AG - Business segments
Bayer AG - Key news
Bayer AG - Key offerings
Bayer AG - Segment focus
11.6 Eisai Co. Ltd.
Eisai Co. Ltd. - Overview
Eisai Co. Ltd. - Business segments
Eisai Co. Ltd. - Key offerings
Eisai Co. Ltd. - Segment focus
11.7 GlaxoSmithKline Plc
GlaxoSmithKline Plc - Overview
GlaxoSmithKline Plc - Business segments
GlaxoSmithKline Plc - Key news
GlaxoSmithKline Plc - Key offerings
GlaxoSmithKline Plc - Segment focus
11.8 Ipsen Pharma
Ipsen Pharma - Overview
Ipsen Pharma - Business segments
Ipsen Pharma - Key offerings
Ipsen Pharma - Segment focus
11.9 Johnson and Johnson Services Inc.
Johnson and Johnson Services Inc. - Overview
Johnson and Johnson Services Inc. - Business segments
Johnson and Johnson Services Inc. - Key news
Johnson and Johnson Services Inc. - Key offerings
Johnson and Johnson Services Inc. - Segment focus
11.10 Karyopharm Therapeutics Inc.
Karyopharm Therapeutics Inc. - Overview
Karyopharm Therapeutics Inc. - Product / Service
Karyopharm Therapeutics Inc. - Key offerings
11.11 Novartis AG
Novartis AG - Overview
Novartis AG - Business segments
Novartis AG - Key news
Novartis AG - Key offerings
Novartis AG - Segment focus
11.12 PharmaMar SA
PharmaMar SA - Overview
PharmaMar SA - Business segments
PharmaMar SA - Key offerings
PharmaMar SA - Segment focus

12 Appendix
12.1 Scope of the report
12.2 Inclusions and exclusions checklist
Inclusions checklist
Exclusions checklist
12.3 Currency conversion rates for US$
Currency conversion rates for US$
12.4 Research methodology
Research methodology
12.5 Data procurement
Information sources
12.6 Data validation
Data validation
12.7 Validation techniques employed for market sizing
Validation techniques employed for market sizing
12.8 Data synthesis
Data synthesis
12.9 360 degree market analysis
360 degree market analysis
12.10 List of abbreviations
List of abbreviations

Exhibits:
Exhibits1: Executive Summary - Chart on Market Overview
Exhibits2: Executive Summary - Data Table on Market Overview
Exhibits3: Executive Summary - Chart on Global Market Characteristics
Exhibits4: Executive Summary - Chart on Market by Geography
Exhibits5: Executive Summary - Chart on Market Segmentation by Type
Exhibits6: Executive Summary - Chart on Incremental Growth
Exhibits7: Executive Summary - Data Table on Incremental Growth
Exhibits8: Executive Summary - Chart on Company Market Positioning
Exhibits9: Parent Market
Exhibits10: Data Table on - Parent Market
Exhibits11: Market characteristics analysis
Exhibits12: Value Chain Analysis
Exhibits13: Offerings of companies included in the market definition
Exhibits14: Market segments
Exhibits15: Chart on Global - Market size and forecast 2023-2028 ($ million)
Exhibits16: Data Table on Global - Market size and forecast 2023-2028 ($ million)
Exhibits17: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits18: Data Table on Global Market: Year-over-year growth 2023-2028 (%)
Exhibits19: Historic Market Size - Data Table on Global Sarcoma Therapeutics Market 2018 - 2022 ($ million)
Exhibits20: Historic Market Size - Type Segment 2018 - 2022 ($ million)
Exhibits21: Historic Market Size - Geography Segment 2018 - 2022 ($ million)
Exhibits22: Historic Market Size - Country Segment 2018 - 2022 ($ million)
Exhibits23: Five forces analysis - Comparison between 2023 and 2028
Exhibits24: Bargaining power of buyers - Impact of key factors 2023 and 2028
Exhibits25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
Exhibits26: Threat of new entrants - Impact of key factors in 2023 and 2028
Exhibits27: Threat of substitutes - Impact of key factors in 2023 and 2028
Exhibits28: Threat of rivalry - Impact of key factors in 2023 and 2028
Exhibits29: Chart on Market condition - Five forces 2023 and 2028
Exhibits30: Chart on Type - Market share 2023-2028 (%)
Exhibits31: Data Table on Type - Market share 2023-2028 (%)
Exhibits32: Chart on Comparison by Type
Exhibits33: Data Table on Comparison by Type
Exhibits34: Chart on Soft tissue sarcoma - Market size and forecast 2023-2028 ($ million)
Exhibits35: Data Table on Soft tissue sarcoma - Market size and forecast 2023-2028 ($ million)
Exhibits36: Chart on Soft tissue sarcoma - Year-over-year growth 2023-2028 (%)
Exhibits37: Data Table on Soft tissue sarcoma - Year-over-year growth 2023-2028 (%)
Exhibits38: Chart on Osteosarcoma - Market size and forecast 2023-2028 ($ million)
Exhibits39: Data Table on Osteosarcoma - Market size and forecast 2023-2028 ($ million)
Exhibits40: Chart on Osteosarcoma - Year-over-year growth 2023-2028 (%)
Exhibits41: Data Table on Osteosarcoma - Year-over-year growth 2023-2028 (%)
Exhibits42: Market opportunity by Type ($ million)
Exhibits43: Data Table on Market opportunity by Type ($ million)
Exhibits44: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits45: Chart on Market share by geography 2023-2028 (%)
Exhibits46: Data Table on Market share by geography 2023-2028 (%)
Exhibits47: Chart on Geographic comparison
Exhibits48: Data Table on Geographic comparison
Exhibits49: Chart on North America - Market size and forecast 2023-2028 ($ million)
Exhibits50: Data Table on North America - Market size and forecast 2023-2028 ($ million)
Exhibits51: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibits52: Data Table on North America - Year-over-year growth 2023-2028 (%)
Exhibits53: Chart on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits54: Data Table on Europe - Market size and forecast 2023-2028 ($ million)
Exhibits55: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibits56: Data Table on Europe - Year-over-year growth 2023-2028 (%)
Exhibits57: Chart on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits58: Data Table on Asia - Market size and forecast 2023-2028 ($ million)
Exhibits59: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibits60: Data Table on Asia - Year-over-year growth 2023-2028 (%)
Exhibits61: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits62: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ million)
Exhibits63: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits64: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibits65: Chart on US - Market size and forecast 2023-2028 ($ million)
Exhibits66: Data Table on US - Market size and forecast 2023-2028 ($ million)
Exhibits67: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibits68: Data Table on US - Year-over-year growth 2023-2028 (%)
Exhibits69: Chart on China - Market size and forecast 2023-2028 ($ million)
Exhibits70: Data Table on China - Market size and forecast 2023-2028 ($ million)
Exhibits71: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibits72: Data Table on China - Year-over-year growth 2023-2028 (%)
Exhibits73: Chart on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits74: Data Table on Germany - Market size and forecast 2023-2028 ($ million)
Exhibits75: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibits76: Data Table on Germany - Year-over-year growth 2023-2028 (%)
Exhibits77: Chart on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits78: Data Table on Canada - Market size and forecast 2023-2028 ($ million)
Exhibits79: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibits80: Data Table on Canada - Year-over-year growth 2023-2028 (%)
Exhibits81: Chart on UK - Market size and forecast 2023-2028 ($ million)
Exhibits82: Data Table on UK - Market size and forecast 2023-2028 ($ million)
Exhibits83: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibits84: Data Table on UK - Year-over-year growth 2023-2028 (%)
Exhibits85: Market opportunity by geography ($ million)
Exhibits86: Data Tables on Market opportunity by geography ($ million)
Exhibits87: Impact of drivers and challenges in 2023 and 2028
Exhibits88: Overview on criticality of inputs and factors of differentiation
Exhibits89: Overview on factors of disruption
Exhibits90: Impact of key risks on business
Exhibits91: Companies covered
Exhibits92: Matrix on companies position and classification
Exhibits93: Agios Inc. - Overview
Exhibits94: Agios Inc. - Product / Service
Exhibits95: Agios Inc. - Key offerings
Exhibits96: Athenex Inc. - Overview
Exhibits97: Athenex Inc. - Product / Service
Exhibits98: Athenex Inc. - Key offerings
Exhibits99: Bayer AG - Overview
Exhibits100: Bayer AG - Business segments
Exhibits101: Bayer AG - Key news
Exhibits102: Bayer AG - Key offerings
Exhibits103: Bayer AG - Segment focus
Exhibits104: Eisai Co. Ltd. - Overview
Exhibits105: Eisai Co. Ltd. - Business segments
Exhibits106: Eisai Co. Ltd. - Key offerings
Exhibits107: Eisai Co. Ltd. - Segment focus
Exhibits108: GlaxoSmithKline Plc - Overview
Exhibits109: GlaxoSmithKline Plc - Business segments
Exhibits110: GlaxoSmithKline Plc - Key news
Exhibits111: GlaxoSmithKline Plc - Key offerings
Exhibits112: GlaxoSmithKline Plc - Segment focus
Exhibits113: Ipsen Pharma - Overview
Exhibits114: Ipsen Pharma - Business segments
Exhibits115: Ipsen Pharma - Key offerings
Exhibits116: Ipsen Pharma - Segment focus
Exhibits117: Johnson and Johnson Services Inc. - Overview
Exhibits118: Johnson and Johnson Services Inc. - Business segments
Exhibits119: Johnson and Johnson Services Inc. - Key news
Exhibits120: Johnson and Johnson Services Inc. - Key offerings
Exhibits121: Johnson and Johnson Services Inc. - Segment focus
Exhibits122: Karyopharm Therapeutics Inc. - Overview
Exhibits123: Karyopharm Therapeutics Inc. - Product / Service
Exhibits124: Karyopharm Therapeutics Inc. - Key offerings
Exhibits125: Novartis AG - Overview
Exhibits126: Novartis AG - Business segments
Exhibits127: Novartis AG - Key news
Exhibits128: Novartis AG - Key offerings
Exhibits129: Novartis AG - Segment focus
Exhibits130: PharmaMar SA - Overview
Exhibits131: PharmaMar SA - Business segments
Exhibits132: PharmaMar SA - Key offerings
Exhibits133: PharmaMar SA - Segment focus
Exhibits134: Inclusions checklist
Exhibits135: Exclusions checklist
Exhibits136: Currency conversion rates for US$
Exhibits137: Research methodology
Exhibits138: Information sources
Exhibits139: Data validation
Exhibits140: Validation techniques employed for market sizing
Exhibits141: Data synthesis
Exhibits142: 360 degree market analysis
Exhibits143: List of abbreviations

この商品のレポートナンバー

0000039456

TOP